Primary liver tumours (ie hepatocellular carcinoma (HCC) or intrahepatic
cholangiocarcinoma (ICC)) are among the most frequent cancers worldwide. However, only …

Inert microspheres, labeled with several radionuclides, have been developed during the last
two decades for the intra-arterial treatment of liver tumors, generally called Selective …

Trans-arterial radioembolization is currently performed using 90Y-loaded glass or resin
microspheres and also using 166Ho-loaded microspheres. The goal of this review is to …

PURPOSE To study the impact of transarterial Yttrium-90 radioembolization (TARE) in
combination with second-line systemic chemotherapy for colorectal liver metastases (CLM) …

Partition model (PM) for Y-90 microsphere radioembolization is limited in providing 3D
dosimetrics. Voxel-S-Values (VSV) method has good agreement with Monte Carlo (MC) …

Background In radioembolization, response is achieved through the irradiation and
damaging of tumor DNA. For hepatic metastases of neuroendocrine tumors, a dose …

Selective internal radiation therapy (SIRT) is one of the treatment options for liver tumors.
Microspheres labelled with a therapeutic radionuclide (90Y or 166Ho) are injected into the …

Background: In the context of the coronavirus disease 2019 (COVID-19) pandemic, liver-
directed therapies (LDTs) may offer minimally invasive integrative tools for tumor control …

Simple Summary Radioembolization has failed to prove survival benefit in randomized trials,
and, depending on various factors including tumor biology, response rates may vary …

Simple Summary Colorectal liver metastases are difficult to treat, with only a minority of
patients eligible for surgical resection. Yttrium-90 selective internal radiation therapy is an …